Loading...
Loading...

Incorporated in 2021, Speciality Medicines Limited markets and distributes specialty pharmaceuticals, including high-cost medications for chronic conditions, in India and internationally. The company offers over 650 products, focusing on various therapeutic areas, and includes human and animal medicines, vaccines, and plasma products sourced from compliant manufacturers. As of July 31, 2024, it employs 20 permanent staff across departments.
Timeline information will be updated when available.
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 0.95% | Partially Subscribed |
| NII (Non-Institutional Investors/HNI) | 49.50% | Oversubscribed |
| RII (Retail Individual Investors) | 49.55% | Oversubscribed |
| Total Subscription | Undersubscribed |
Last updated: Percentage of shares offered
Potential challenges and risk factors